NDC11 00074703201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00074-7032-01 | 00074-7032 |
| 00074-7032-1 | 00074-7032 |
| 0074-7032-01 | 0074-7032 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Skyrizi | RISANKIZUMAB-RZAA | AbbVie Inc. | 7148c8eb-b39e-e20a-6494-a6df82392858 | 2026-06-15 | Warnings, Adverse reactions | 0074-7032-01 00074703201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.